Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma
Juncheng Cui(First Affiliated Hospital of University of South China), Zhenfeng Duan(Sylvester Comprehensive Cancer Center)
Cited by 29
Related Papers
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
|Oncotarget|2016|74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
|Journal of Orthopaedic Research®|2020|30